🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the therapeutic equivalence between the two arms of treatment i...
Status
Completed
Location
Institute of Infections and Tropical Diseases University of Brescia
Start Date
2004-04
Trial ID
NCT00318123
Treatments Being Tested
The goal of this clinical study is to learn more about the effects of switc...
Status
Active Not Recruiting
Location
Be Well Medical Center
Start Date
2022-08-16
Trial ID
NCT05502341
Treatments Being Tested
More than 150,000 babies became infected with HIV in 2015 alone. When HIV d...
Status
Completed
Location
St. Monica's Hospital
Start Date
2017-12-22
Trial ID
NCT03284645
Once-daily nucleotide/nucleoside reverse transcriptase inhibitor (NtRTI/NRT...
Status
Completed
Location
UCI
Start Date
2004-12-07
Trial ID
NCT00214890
Dolutegravir is a potent integrase strand transfer inhibitor. Abacavir/dolu...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-06-06
Trial ID
NCT03016533
The primary objective of this study is to evaluate the efficacy of a fixed ...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2015-11-13
Trial ID
NCT02607930
Treatments Being Tested
Dolutegravir (DTG, GSK1349572) is a next-generation integrase inhibitor (IN...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-06
Trial ID
NCT01366547
The primary objective of this study is to assess glomerular function before...
Status
Completed
Location
Multiple Locations
Start Date
2014-12-15
Trial ID
NCT02246998
This study is a Phase IIb, randomized, multicentre, parallel group, open-la...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-04-28
Trial ID
NCT02120352
Treatments Being Tested
This study was designed to test the efficacy, safety, tolerability and dura...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-03
Trial ID
NCT00440947